HomeInsightsPE

Gujarat Themis Biosyn Ltd PE Ratio

Gujarat Themis Biosyn Ltd PE Ratio

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

24.1 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PE

64.4

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Gujarat Themis Biosyn Ltd is 64.4 as of 24 Nov 14:11 PM .
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 8.9 on March 2019 to 48.7 on March 2024 . This represents a CAGR of 32.75% over 6 years.
  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 311.95 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

No data available

Company Fundamentals for Gujarat Themis Biosyn Ltd

No data available

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

Share Price

₹ 311.95

-6.00 (-1.89%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Gujarat Themis Biosyn Ltd

1M

1Y

3Y

5Y

Monitoring Gujarat Themis Biosyn Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024311.95
21 Nov 2024317.95
19 Nov 2024327.95
18 Nov 2024304.8
14 Nov 2024294.1
13 Nov 2024293.35
12 Nov 2024317.25
11 Nov 2024323.85
08 Nov 2024327.15
07 Nov 2024320

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gujarat Themis Biosyn Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Gujarat Themis Biosyn Ltd643,399
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Gujarat Themis Biosyn Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Revenue of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical EBITDA of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Net Profit of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gujarat Themis Biosyn Ltd

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

Gujarat Themis Biosyn Ltd News Hub

News

Gujarat Themis Biosyn standalone net profit declines 15.71% in the September 2024 quarter

Net profit of Gujarat Themis Biosyn declined 15.71% to Rs 10.57 crore in the quarter ended...

Read more

2024-10-25 00:00:00

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 O...

Read more

2024-10-19 00:00:00

News

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have appr...

Read more

2024-11-19 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gujarat Themis Biosyn Ltd

What is the current PE Ratio of Gujarat Themis Biosyn Ltd?

The Current PE Ratio of Gujarat Themis Biosyn Ltd is 64.45 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Gujarat Themis Biosyn Ltd last year?

The PE Ratio of Gujarat Themis Biosyn Ltd was 17.2 last year, now the PE ratio is 64.45, showing a year-on-year growth of 274.7%.

What does the PE Ratio of Gujarat Themis Biosyn Ltd indicate about its stock?

The PE Ratio of Gujarat Themis Biosyn Ltd is 64.45. This ratio indicates that investors are willing to pay 64.45 times the earnings per share for each share of Gujarat Themis Biosyn Ltd.

What is the PE Ratio Growth of Gujarat Themis Biosyn Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gujarat Themis Biosyn Ltd grew by 274.7% whereas, the EPS ratio grew by -46.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*